Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check8 days agoChange DetectedPublications section now includes a new 2026 JACC Heart Fail citation (with authors) and updates the prior Eur J Heart Fail citation to a later version. This updates the study’s referenced literature and author information.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page adds a Circ Heart Fail publication (2026 ahead of print) and updates the revision tag to v3.4.1, replacing v3.4.0. These are minor metadata updates that do not alter core study content, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded the 2026 JACC Heart Fail publication by Ostrominski et al. titled 'Finerenone and NYHA Functional Class in Heart Failure: The FINEARTS-HF Trial' and removed the 2025 online-ahead-of-print citation with the same topic.SummaryDifference0.0%

- Check31 days agoChange DetectedThe Study Details page has new labels 'Results First Posted' and 'Last Update Posted' in the Study Record Dates, and the '(Estimated)' variants have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded a new author list for the FINEARTS-HF anaemia analysis publication (Eur J Heart Fail. 2025). Removed the 'on behalf of the FINEARTS-HF Committees and Investigators' attribution from the citation.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.